Brings on Landmark To Provide Home-Based Care
Care is moving homeward, driven by patient preference and more importantly, cost.
HEALTHCARE: Positive momentum; foresees FDA OK
The past couple of years have been difficult for Endologix Inc. (Nasdaq: ELGX), but conditions appear to be improving at the Irvine-based medical device maker, with a repositioned portfolio and a new leader at the helm.
It’s Top Online Seller; Seeks Larger Headquarters
“First, I am not Bob,” said Bob’s Watches owner Paul Altieri.
Irvine-based Evolus Inc.’s stock (Nasdaq: EOLS) have taken a rollercoaster ride this week. Shares earlier buoyed by news of its new chief executive dove today when it gave updates related to the regulatory progress on the pending approval of its drug candidate DWP-450.
HEALTHCARE: Wants to make drug big-brand contender
Wall Street is pleased with Evolus Inc.’s (Nasdaq: EOLS) new president and chief executive, David Moatazedi, as shares of the company shot up more than 40% since the news broke on May 7.
First Commercially Available Treatment
Edwards Lifesciences Corp. (NYSE: EW) continues pushing the envelope on cutting-edge transcatheter cardiovascular therapies, recently receiving European CE Mark approval for the Cardioband Tricuspid Valve Reconstruction System for the treatment of tricuspid regurgitation.
OCTANe Forum Soon; Presents Eight
Aliso Viejo-based accelerator OCTANe will showcase eight LaunchPad companies at its annual Technology Innovation Forum at the Newport Beach Hotel & Spa from May 31 to June 1.
HEALTHCARE: 20-plus years later, device co. plans for FDA nod
Irvine-based TherOx Inc. secured debt financing this month from existing investor Zoll Medical Corp. to support a limited launch of its SuperSaturated Oxygen therapy system upon receipt of Food and Drug Administration approval.
Seeks $2 Million, Plans To Add Blockchain
The cannabis industry is booming, generating $9.7 billion in North America last year, up 33% over 2016, according to a report by Arcview Market Research and BDS Analytics that predicts the market will reach $24.5 billion in sales by 2021.
Allergan Plc named Carrie Strom as senior vice president of U.S. Medical Aesthetics, reporting to Chief Commercial Officer Bill Meury.